Ultragenyx Pharmaceutical Inc (RARE)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$44.13

Buy

$46.22

arrow-up$1.35 (+3.08%)

Prices updated at 20 Nov 2024, 00:54 EST
| Prices minimum 15 mins delay
|
Prices in USD
Ultragenyx Pharmaceutical Inc is biopharmaceutical company. It is engaged identification, acquisition, development and commercialization of novel products for treatment of rare & ultra-rare diseases, with a focus on debilitating genetic diseases.
NASDAQ
arrow-up1.04%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$45.15 - $43.38
$60.37 - $37.02
-
5,016.55m
-
-
1,063,718
11.66
834,215.02
0.11
82.33m
US90400D1081
-6.35
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.